Deep brain stimulation is increasingly used in the treatment of Parkinson's disease, essential tremor and other disorders, yet its mechanism of action remains unknown. New findings suggest that at least some of its action involves the release of adenosine, dampening tremors (pages 75–80).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer
Cell Death & Disease Open Access 16 May 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lozano, A.M. & Eltahawy, H. Suppl. Clin. Neurophysiol. 57, 733–736 (2004).
Bekar, L. et al. Nat. Med. 14, 75–80 (2008).
Fukumitsu, N. et al. J. Nucl. Med. 46, 32–37 (2005).
Jacobson, K.A. & Gao, Z.G. Nat. Rev. Drug Discov. 5, 247–264 (2006).
Hubble, J.P. et al. Neurology 46, 1150–1153 (1996).
Rehncrona, S. et al. Mov. Disord. 18, 163–170 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Asaad, W., Eskandar, E. The movers and shakers of deep brain stimulation. Nat Med 14, 17–19 (2008). https://doi.org/10.1038/nm0108-17
Issue Date:
DOI: https://doi.org/10.1038/nm0108-17
This article is cited by
-
Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer
Cell Death & Disease (2019)